BACKGROUND: Coronary arterial disease is the major cause of congestive heart failure, but suitable animal models of postinfarction, dilated cardiomyopathy do not exist. This article describes an ovine model that develops after an anterobasal infarction. METHODS: The distribution of ovine myocardium supplied by the first two diagonal branches of the left homonymous artery were determined in 20 slaughterhouse hearts and eight live sheep using methylene blue and tetrazolium injections, respectively. Seven additional animals had the infarction and underwent serial hemodynamic, microsphere and echocardiographic studies more than 8 weeks and histologic studies at the eighth week. Infarcts represented 24.6% +/- 4.7% and 23.9% +/- 2.2% of the left ventricular mass in slaughterhouse and live hearts, respectively. RESULTS: During remodeling, left ventricular end-systolic and end-diastolic volumes increased 115% and 73%, respectively, ejection fraction decreased from 41.2% +/- 6.7% to 29.1% +/- 5.7%, systolic wall thickening remote from the infarct decreased by 68%, sphericity index increased from 0.465 +/- 0.088 to 0.524 +/- 0.038, and left ventricular end-diastolic pressure increased from 1.7 +/- 1.0 to 8.2 +/- 3.5 mm Hg. Serial microsphere measurements documented normal blood flow (1.34 mL/g per minute) to all uninfarcted myocardium and 22% of normal to the infarct. Viable myocardium showed mild interstitial fibrosis. CONCLUSIONS: This ovine model meets all criteria for postinfarction, dilated cardiomyopathy and has the advantages of controlling for variations in coronary arterial anatomy, collateral vascularity, and differences in the numbers, location, and severity of atherosclerotic lesions that confound human studies of the pathogenesis of this disease. This simple model contains only infarcted and fully perfused, hypocontractile myocardium produced by a moderate-sized, regional infarction.
BACKGROUND:Coronary arterial disease is the major cause of congestive heart failure, but suitable animal models of postinfarction, dilated cardiomyopathy do not exist. This article describes an ovine model that develops after an anterobasal infarction. METHODS: The distribution of ovine myocardium supplied by the first two diagonal branches of the left homonymous artery were determined in 20 slaughterhouse hearts and eight live sheep using methylene blue and tetrazolium injections, respectively. Seven additional animals had the infarction and underwent serial hemodynamic, microsphere and echocardiographic studies more than 8 weeks and histologic studies at the eighth week. Infarcts represented 24.6% +/- 4.7% and 23.9% +/- 2.2% of the left ventricular mass in slaughterhouse and live hearts, respectively. RESULTS: During remodeling, left ventricular end-systolic and end-diastolic volumes increased 115% and 73%, respectively, ejection fraction decreased from 41.2% +/- 6.7% to 29.1% +/- 5.7%, systolic wall thickening remote from the infarct decreased by 68%, sphericity index increased from 0.465 +/- 0.088 to 0.524 +/- 0.038, and left ventricular end-diastolic pressure increased from 1.7 +/- 1.0 to 8.2 +/- 3.5 mm Hg. Serial microsphere measurements documented normal blood flow (1.34 mL/g per minute) to all uninfarcted myocardium and 22% of normal to the infarct. Viable myocardium showed mild interstitial fibrosis. CONCLUSIONS: This ovine model meets all criteria for postinfarction, dilated cardiomyopathy and has the advantages of controlling for variations in coronary arterial anatomy, collateral vascularity, and differences in the numbers, location, and severity of atherosclerotic lesions that confound human studies of the pathogenesis of this disease. This simple model contains only infarcted and fully perfused, hypocontractile myocardium produced by a moderate-sized, regional infarction.
Authors: Paola Locatelli; Fernanda D Olea; Andrea De Lorenzi; Fabián Salmo; Gustavo L Vera Janavel; Anna P Hnatiuk; Eduardo Guevara; Alberto J Crottogini Journal: Int J Clin Exp Med Date: 2011-10-22
Authors: Michael G Katz; Anthony S Fargnoli; Catherine E Tomasulo; Louella A Pritchette; Charles R Bridges Journal: J Gene Med Date: 2011-10 Impact factor: 4.565
Authors: Hylton P Gordon; Michael G Katz; Shahood Fazal; Virginia L Gillespie; Anthony S Fargnoli; Sarah M Gubara; Sophia J Madjarova; Jonathan A Cohen Journal: Comp Med Date: 2021-06-03 Impact factor: 0.982
Authors: Abhijit Mondal; John Lackey; Mossab Saeed; Fei-Yi Wu; Jordan K Johnson; Chao Huang; Frank B Sachse; Robert Hitchcock; Aditya K Kaza Journal: Semin Thorac Cardiovasc Surg Date: 2019-02-06
Authors: Kanji Matsuzaki; Masato Morita; Hirotsugu Hamamoto; Mio Noma; J Daniel Robb; Matthew J Gillespie; Joseph H Gorman; Robert C Gorman Journal: Ann Thorac Surg Date: 2010-09 Impact factor: 4.330
Authors: Jan D Schmitto; Suyog A Mokashi; Lawrence S Lee; Rita Laurence; Hanna Schotola; Otavio Coelho-Filho; Taufiek K Rajab; Raymond Kwong; R Morton Bolman; Michael Quintel; Lawrence H Cohn; Frederick Y Chen Journal: Artif Organs Date: 2010-11 Impact factor: 3.094
Authors: Hirotsugu Hamamoto; Joseph H Gorman; Liam P Ryan; Robin Hinmon; Timothy P Martens; Michael D Schuster; Theodore Plappert; Matti Kiupel; Martin G St John-Sutton; Silviu Itescu; Robert C Gorman Journal: Ann Thorac Surg Date: 2009-03 Impact factor: 4.330
Authors: Jennifer A Dixon; Robert C Gorman; Robert E Stroud; Shenikqua Bouges; Hamamoto Hirotsugu; Joseph H Gorman; Timothy P Martens; Silviu Itescu; Michael D Schuster; Theodore Plappert; Martin G St John-Sutton; Francis G Spinale Journal: Circulation Date: 2009-09-15 Impact factor: 29.690
Authors: Adrienne Dardenne; Carlos Fernandez; Alyssa Wagner; Krzysztof Milewski; Diane R Ordanes; Patricia A Mount; Yanping Cheng; Geng-Hua Yi; Gerard B Conditt; Armando Tellez; Greg L Kaluza; Juan F Granada; William P Feeney Journal: J Am Assoc Lab Anim Sci Date: 2013 Impact factor: 1.232